UK plans short-term measures to boost clinical trials
This article was originally published in SRA
The UK government plans to introduce a number of short-term "domestic measures", which are intended to demonstrate that far from gold-plating the EU Clinical Trials Directive, "this country is ready to be a leader in proportionate regulation"1,2.
You may also be interested in...
The European Directorate for the Quality of Medicines & HealthCare is proceeding carefully to find the right balance between serving the diverse requirements of various stakeholders that make use of its ‘certificates of suitability.’
The International Pharmaceutical Regulators Programme has documented various approaches currently being used for the clinical comparability of biosimilar monoclonal antibodies in different jurisdictions.
Remote inspections are here to stay, and global regulators are aligning efforts to develop consensus on how these should be conducted.